Compare FIEE & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FIEE | CVRX |
|---|---|---|
| Founded | 1977 | 2000 |
| Country | Hong Kong | United States |
| Employees | 30 | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.0M | 23.1M |
| IPO Year | 2010 | 2021 |
| Metric | FIEE | CVRX |
|---|---|---|
| Price | $3.02 | $0.68 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $2.25 |
| AVG Volume (30 Days) | 2.3K | ★ 759.4K |
| Earning Date | 11-24-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 107.46 | 23.02 |
| EPS | ★ 0.17 | N/A |
| Revenue | $47,988,549.00 | ★ $56,651,000.00 |
| Revenue This Year | N/A | $3.89 |
| Revenue Next Year | N/A | $12.45 |
| P/E Ratio | $17.47 | ★ N/A |
| Revenue Growth | ★ 27.58 | 10.45 |
| 52 Week Low | $1.50 | $0.67 |
| 52 Week High | $10.59 | $10.28 |
| Indicator | FIEE | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 40.80 | 21.70 |
| Support Level | $2.70 | N/A |
| Resistance Level | $3.32 | $1.55 |
| Average True Range (ATR) | 0.22 | 0.15 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 43.55 | 1.04 |
FiEE Inc is a digital service provider focused on integrating artificial intelligence (AI) and data analytics into content creation, digital authentication, and brand management. Its business model leverages a cloud-based SaaS platform designed to support clients in developing, managing, and optimizing their digital presence across platforms, including customized graphics and posts, short videos, and editorial calendars aligned with brand goals. Additionally, it offers comprehensive software development and maintenance services, delivering custom software solutions from system design and development to deployment and post-launch maintenance. It services consist of three core areas: digital content and MCN services, software development services, and digital authentication services.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.